Efficacy of low‑， medium‑， and standard‑dose rituximab in the treatment of membranous nephropathy

ObjectiveTo evaluate the efficacy of low， medium， and standard doses of rituximab in patients with membranous nephropathy （MN）.MethodsThis retrospective study included 100 MN patients treated with rituximab in the Department of Nephrology at Huaihai Hospital Affiliated to Xuzhou Medical University f...

Descripció completa

Dades bibliogràfiques

Autors principals:	Guo Meng-ling, Wan Wen-li, Li Jia-yue, Wu Shun, Ruan Zhen-min, Wang Rui, Zhang Zhao-yong, Geng Xin, Hu Xue-qing, Ren Hong-qi
Format:	Artigo
Idioma:	Chinês
Publicat:	Editorial Department of Journal of Clinical Nephrology 2026-01-01
Col·lecció:	Linchuang shenzangbing zazhi
Matèries:	Membranous nephropathy Rituximab Small dose Medium dose Standard dose
Accés en línia:	http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2026.01.007
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!